Jackson Walker LLP Bets on Texas Expertise as Competitors Expand Nationwide

Jackson Walker LLP, one of Texas’s prominent law firms, is banking on its deep-rooted presence in the state to maintain a competitive advantage as several local rivals expand their operations beyond Texas borders. This strategy reflects a growing trend among regional law firms to leverage local expertise while larger firms diversify geographically. With a robust…

Read More

Mead Johnson Wins Defense Verdict in Landmark Federal Case on Infant Formula Safety

In a pivotal legal battle, Mead Johnson has secured a defense verdict in the first federal trial concerning the alleged link between cow’s milk-based infant formula and necrotizing enterocolitis (NEC), a severe gastrointestinal illness. This trial, overseen by U.S. Senior District Judge Rebecca Pallmeyer, is part of a larger multidistrict litigation involving more than 800…

Read More

Holland & Knight Expands Health Policy Expertise with Ashley Stark’s Strategic Hire

Holland & Knight has made a significant addition to its healthcare and public policy practice by hiring Ashley Stark, a prominent health policy lawyer from McDermott Will & Emery. Stark joins the firm’s Washington, D.C. office, strengthening its capabilities in navigating the intricate legislative and regulatory landscape affecting the health sector. With extensive experience in…

Read More

Opioid Crisis Litigation Intensifies: OptumRx and Express Scripts Appeal Judge’s Ruling Allowing New Lawsuits

Amid ongoing legal battles surrounding the opioid crisis, pharmacy benefit managers OptumRx and Express Scripts have petitioned the U.S. Court of Appeals for the Sixth Circuit. Their appeal seeks to reverse U.S. District Judge Dan Polster’s July 27 order, which opened the doors for 800 plaintiffs to sue them. The case highlights the increasingly complex…

Read More

Delaware Court Allows Guardant Health’s Patent Lawsuit Against Tempus AI to Proceed, Impacting Biotech and AI Sectors

In a significant development within the realm of biotechnology and artificial intelligence, a Delaware federal judge has decided not to dismiss patent infringement litigation brought by Guardant Health Inc. against Tempus AI Inc. The lawsuit centers on allegations that Tempus AI violated Guardant’s patents, which cover technology pivotal for analyzing cancer-related genetic data to enhance…

Read More

Fujifilm Strengthens Legal Team with Appointment of Erika Sandoval as Americas Chief Counsel

Fujifilm Holdings Corporation has announced the appointment of an experienced legal professional as its new top lawyer for the Americas. Erika Sandoval has been selected for the position, bringing extensive expertise from her previous role as the General Counsel at Elekta, a major player in the cancer treatment technology sector. Sandoval’s transition to Fujifilm aligns…

Read More

Federal Judge Allows Eton Pharmaceuticals to Pursue Legal Claims Against Extreme V Over Misleading Wilson Disease Supplement Marketing

Eton Pharmaceuticals has secured a critical judicial nod to advance its legal battle against Extreme V, over claims that the latter company falsely advertised its dietary supplement as a treatment for Wilson disease. A federal judge in Michigan determined that the defenses and factual counterarguments presented by Extreme V did not suffice to dismiss Eton’s…

Read More

Genesis Healthcare’s Legal Battle Highlights Increasing Tensions Over Healthcare Trade Secrets

Genesis Healthcare recently lodged a complaint against a former executive of its subsidiary, LTC ACO LLC, alleging the theft of corporate documents and trade secrets to establish a competing entity. This legal maneuver, initiated on August 25, underscores the increasing tension in the healthcare sector regarding the protection of proprietary information. The complaint, filed in…

Read More

Delaware Court Clears Lupin to Launch Generic Cystic Fibrosis Drug in Landmark Patent Case

In a significant development for the pharmaceutical industry, a Delaware federal court recently ruled in favor of Lupin Ltd. in a patent infringement lawsuit brought by Vertex Pharmaceuticals Inc. The case centered on Vertex’s allegations that Lupin’s planned generic version of a cystic fibrosis treatment violated patents held by Vertex. The court found that Lupin’s…

Read More

U.S. Weighs $100,000 H-1B Fee Shift, Sparking Debate Over Economic and Workforce Impacts

The U.S. government is considering a proposal that would impose a $100,000 fee on certain H-1B visa holders wishing to transition to permanent residency. This fee could significantly impact tech companies and other industries relying on a skilled foreign workforce. The proposal primarily targets visa holders who are already in the U.S., seeking to adjust…

Read More

Humanitarian Aid Cuts Threaten Health and Nutrition of Somali Children Amid Escalating Crisis

The United Nations has sounded an alarm over significant reductions in global humanitarian aid, an issue that has severe implications for children in Somalia. According to recent updates from the UN Children’s Fund (UNICEF), the cuts have resulted in the closure of over 200 health and nutrition facilities across Somalia, leaving children without essential healthcare,…

Read More

Rising Violence in South Sudan: A Growing Threat to 2026 Elections and Fragile Peace

As South Sudan approaches a significant moment in its political history with the upcoming elections slated for December 2026, renewed violence threatens to derail the nation’s fragile peace process. Reports from the UN Commission on Human Rights in South Sudan highlight the troubling rise in violence and atrocity crimes that have emerged, disrupting the ongoing…

Read More

FTC Challenges Amgen’s Patent Acquisition Strategy in High-Stakes Antitrust Appeal

In a significant legal confrontation, the Federal Trade Commission (FTC) has called on the Fourth Circuit to dismiss Amgen Inc.’s argument that commercial agreements for acquiring patent rights are inherently immune to antitrust reviews. This legal dispute arises amidst an appeal concerning Enbrel, Amgen’s highly successful autoimmune medication. The FTC contends that Amgen’s stance poses…

Read More

McGuireWoods Strengthens Virginia Presence with Strategic Addition of Veteran Commercial Litigators from Womble Bond Dickinson

McGuireWoods has announced the addition of two experienced commercial litigators from Womble Bond Dickinson to its team in Virginia. This strategic move is intended to enhance the firm’s capabilities in handling complex commercial litigation. According to Bloomberg Law, the new additions come as McGuireWoods seeks to bolster its presence in the southeastern United States, a…

Read More

New York Court Delays Murder Trial Over Double Jeopardy Dispute Following Federal Plea

A recent judicial order in New York has resulted in the indefinite postponement of Luigi Mangione’s state murder trial, as his defense attorneys raise issues of potential double jeopardy. This move follows Mangione’s guilty plea last week to federal charges of stalking in which he admitted to shooting UnitedHealthcare CEO Brian Thompson. Prosecutors from the…

Read More

Bradley Arant Strengthens Atlanta Healthcare Practice with Strategic Hire from SCP Health

Bradley Arant Boult Cummings LLP has strategically expanded its healthcare practice by welcoming a new addition to its Atlanta office. The firm recently hired the former senior vice president and associate general counsel of SCP Health. This move is expected to provide Bradley Arant with enhanced expertise and insight into the rapidly evolving healthcare sector,…

Read More

Florida Healthcare Claims Co. Appoints Amanda Lee as New Chief Legal Officer Amid Industry Regulation Changes

Florida Healthcare Claims Co. has announced the appointment of a new Chief Legal Officer (CLO), highlighting its intent to enhance governance and compliance measures within the company. The appointment of Amanda Lee, a seasoned legal expert with over two decades of experience in healthcare law and corporate governance, signals the company’s strategic commitment to navigating…

Read More

Pharmaceutical Industry Faces Setback as D.C. Circuit Upholds Medicare Price Negotiation Authority

The D.C. Circuit’s recent decision represents another chapter in the ongoing legal tussle between the pharmaceutical industry and the federal government over Medicare’s newly minted pricing negotiation capabilities. While the pharmaceutical sector faces a setback, the ruling provides nuanced insights that may inform future litigation strategies. The court’s affirmation aligns with the judgments of other…

Read More

Health Gorilla Strengthens Legal Team with Key Appointment of Former Wilson Sonsini Partner

Health Gorilla, a prominent player in the healthcare technology sector, has bolstered its legal team by appointing a new chief legal officer. This strategic move comes in the wake of the hiring of Jennifer Schumacher, previously a partner at Wilson Sonsini, a well-respected law firm known for its expertise in technology and life sciences. Schumacher’s…

Read More

Paul Weiss Expands Houston Presence with $700,000 Office Buildout Amid Texas Legal Boom

New York-based law firm Paul, Weiss, Rifkind, Wharton & Garrison LLP is making a significant investment in the Houston legal market, as evidenced by a $700,000 office buildout. This strategic move aligns with the firm’s broader efforts to expand its footprint in Texas, an increasingly competitive landscape for legal services. The office expansion is part…

Read More